Skip to content
DilutionScan
Vivakor, Inc. logo
VIVK$0.66-2.94%

Vivakor, Inc.

Sector: Refuse SystemsIndustry: Oil & Gas Equipment & ServicesCountry: USExchange: Nasdaq

Mkt Cap$1.05M
Float & O/S
Inst Own

DilutionScan read 32 of Vivakor, Inc.'s SEC filings and found 5 warrant series, 12 convertibles, 1 equity line, 2 shelf registrations, 1 S-1 registration and 7 completed offerings on file for VIVK. The latest dilution event on file is a note conversion on Oct 9, 2026. Analysis updated Oct 21, 2026.

Signal8 Summary

VIVK

Going-concern warning, three reverse splits

Business
WeakNet loss $110.2M on $104.4M revenue, going-concern warning
Stock risk
High$2.5M micro-cap, 3 reverse splits in 12 months, runway 6.2 months

Snapshot

Vivakor is an energy waste-remediation and crude-trading company with FY 2025 revenue of $104.4M, up 16.3% YoY, but a net loss of $110.2M, far larger than revenue.

What's Happening Right Now

  • : The Railroad Commission of Texas approved Vivakor's P-5 filing for its Houston Remediation Processing Center, advancing it into R-9 permit technical review and keeping the facility on track for targeted commercial operations in Q1 2027.
  • : Vivakor had J.J. Astor & Co. convert $1,972,472.08 of its $5.94M junior secured convertible note into 878,255 freely tradable shares, fully satisfying that note.
  • : Vivakor signed a non-binding LOI to acquire Direct Midstream, a Permian Basin water midstream company, for $40 million (4x targeted 2027 free cash flow), with the deal still subject to diligence, a definitive agreement, and Vivakor funding a $10 million cash investment.
  • : 878.3K shares.
  • : Vivakor completed a 1-for-15 reverse stock split effective October 5, 2026, its second split in three months after a 1-for-20 split in July 2026, both aimed at regaining Nasdaq bid-price compliance.
  • : 603.6K shares.
  • : 40.1K shares.
  • : Vivakor's Q2 2026 10-Q disclosed explicit going-concern language, a $58 million working capital deficit, just $259,749 of cash, and heavy reliance on convertible-note and equity-line financing that pushed shares outstanding from 511,087 to 8,183,626 in about six weeks.

DilutionScan ProEvery instrument in full · $59/mo